AAAAAA

   
Results: 1-10 |
Results: 10
SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP HANNOUDI GN PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1, Clinical cancer research, 4(5), 1998, pp. 1337-1343
SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP HANNOUDI GN PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1, Clinical cancer research, 4(5), 1998, pp. 1337-1343
PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: VARTERASIAN ML MOHAMMAD RM EILENDER DS HULBURD K RODRIGUEZ DH PEMBERTON PA PLUDA JM DAN MD PETTIT GR CHEN BDM ALKATIB AM
Citation: Ml. Varterasian et al., PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(1), 1998, pp. 56-62
TRISOMY-6 AS A PRIMARY KARYOTYPIC ABERRATION IN HEMATOLOGIC DISORDERS
Authors: MOHAMED AN VARTERASIAN ML DOBIN SM MCCONNELL TS WOLMAN SR RANKIN C WILLMAN CL HEAD DR SLOVAK ML
Citation: An. Mohamed et al., TRISOMY-6 AS A PRIMARY KARYOTYPIC ABERRATION IN HEMATOLOGIC DISORDERS, Cancer genetics and cytogenetics, 106(2), 1998, pp. 152-155
PRECLINICAL EVALUATION OF MARINE ANIMAL PRODUCTS IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP LIMVARAPUSS C PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., PRECLINICAL EVALUATION OF MARINE ANIMAL PRODUCTS IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS, Experimental hematology, 25(8), 1997, pp. 396-396
SUCCESSFUL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) XENOGRAFTSWITH MARINE ANIMAL PRODUCTS
Authors: ALKATIB A VARTERASIAN ML ALMATCHY VP PETTIT GR MOHAMMAD RM
Citation: A. Alkatib et al., SUCCESSFUL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) XENOGRAFTSWITH MARINE ANIMAL PRODUCTS, Experimental hematology, 25(8), 1997, pp. 498-498
A BLOOD STEM-CELL TRANSPLANT IN A PERSON WITH CONCOMITANT HODGKIN-DISEASE AND TESTICULAR-CARCINOMA
Authors: VARTERASIAN ML AREF A KARANES C
Citation: Ml. Varterasian et al., A BLOOD STEM-CELL TRANSPLANT IN A PERSON WITH CONCOMITANT HODGKIN-DISEASE AND TESTICULAR-CARCINOMA, Bone marrow transplantation, 19(8), 1997, pp. 857-858
BRYOSTATIN-1 (BRYO1)-INDUCED MONOCYTIC DIFFERENTIATION IN THP-1 - HUMAN LEUKEMIA-CELLS IS ASSOCIATED WITH ENHANCED C-FYN TYROSINE KINASE AND M-CSF RECEPTORS
Authors: LI Y MOHAMMAD RM ALKATIB A VARTERASIAN ML CHEN B
Citation: Y. Li et al., BRYOSTATIN-1 (BRYO1)-INDUCED MONOCYTIC DIFFERENTIATION IN THP-1 - HUMAN LEUKEMIA-CELLS IS ASSOCIATED WITH ENHANCED C-FYN TYROSINE KINASE AND M-CSF RECEPTORS, Leukemia research, 21(5), 1997, pp. 391-397
TUMOR LYSIS SYNDROME IN SMALL-CELL CARCINOMA AND OTHER SOLID TUMORS
Authors: KALEMKERIAN GP DARWISH B VARTERASIAN ML
Citation: Gp. Kalemkerian et al., TUMOR LYSIS SYNDROME IN SMALL-CELL CARCINOMA AND OTHER SOLID TUMORS, The American journal of medicine, 103(5), 1997, pp. 363-367
SEQUENTIAL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) WITH BRYOSTATIN-I AND 2-CHLORODEOXYADENOSINE - A PRECLINICAL STUDY
Authors: KATATO K MOHAMMAD RM DUGAN MC SALEH M AHMAD I ALMATCHY VP VARTERASIAN ML ALKATIB A
Citation: K. Katato et al., SEQUENTIAL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) WITH BRYOSTATIN-I AND 2-CHLORODEOXYADENOSINE - A PRECLINICAL STUDY, Blood, 88(10), 1996, pp. 2349-2349
Risultati: 1-10 |